Charla: "Visualization of complex molecular systems"
Maxime MARIA (Université de Limoges, Francia).

Nowadays, computer simulations are an integral part of research for the design of new drugs. They are performed prior to the long and costly clinical trials in order to quickly and cost-effectively qualify potential drug candidates according to their inhibitory effect on the pathogen. In recent years, 3D visualization has become an essential component to assist theoretical biochemists in the analysis of interactions between molecules and thus facilitate the understanding of their mechanisms of action. At the same time, research in computer graphics has grown considerably. The contributions of this field allow the development of new methods specifically dedicated to the visualization of complex molecular systems.

Bio: Maxime MARIA in an assistant professor (Maître de conférences) since 2019 at the Université de Limoges in France, researcher at the XLIM lab (computer graphics team) and associated to the GBCM lab in Paris. He completed is PhD in 2016, at the University of Poitiers, where he worked on a new type of acceleration structure for ray-tracing. Then, he spent two years as a post-doc at the IGM lab in Paris, working in collaboration with Ubisoft Motion Pictures on geometric data structures for global illumination. From now, he is working on the design of new methods for visualizing molecules to manage increasingly complex simulations while improving image quality. In addition, he is also working on improving camera controls to facilitate the use of visualization software and thus help drug designers in their daily work. His work is used in the VTX molecular visualization software, which he is developing in collaboration with several French laboratories and the company Qubit Pharmaceuticals.

Comunicaciones DCC


  • Tags

Auditorio Ramón Picarte
Facultad de Cs. Físicas y Matemáticas
Universidad de Chile

Beauchef 851, edificio norte, 3er piso

Fecha del evento
27 de Julio de 2022
15:00 - 16:00

Nancy Hitschfeld